Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biote (BTMD) EBIT Margin (2021 - 2025)

Biote (BTMD) has 3 years of EBIT Margin data on record, last reported at 12.05% in Q4 2023.

  • For Q4 2023, EBIT Margin fell 437.0% year-over-year to 12.05%; the TTM value through Dec 2023 reached 15.46%, up 5227.0%, while the annual FY2024 figure was 0.11%, 1535.0% down from the prior year.
  • EBIT Margin reached 12.05% in Q4 2023 per BTMD's latest filing, down from 16.68% in the prior quarter.
  • Across five years, EBIT Margin topped out at 41.1% in Q4 2021 and bottomed at 206.98% in Q2 2022.
  • Average EBIT Margin over 3 years is 1.1%, with a median of 17.57% recorded in 2023.
  • Peak YoY movement for EBIT Margin: crashed -23650bps in 2022, then skyrocketed 22254bps in 2023.
  • A 3-year view of EBIT Margin shows it stood at 41.1% in 2021, then plummeted by -60bps to 16.42% in 2022, then fell by -27bps to 12.05% in 2023.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 12.05% in Q4 2023, 16.68% in Q3 2023, and 15.57% in Q2 2023.